Clinical Decision Support Systems Market worth 1,519.2 Million USD by 2021
This report studies the global clinical decision support systems market over the forecast period of 2016 to 2021. This market is expected to reach USD 1,519.2 Million by 2021 from USD 856.3 Million in 2016, at a CAGR of 12.2%.
(EMAILWIRE.COM, June 26, 2017 ) Browse 104 market data tables and 35 figures spread through 203 pages and in-depth TOC on “Clinical Decision Support Systems Market”
http://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html
Early buyers will receive 10% customization on this report.
In this report, the global CDSS market is segmented on the basis of component, delivery mode, product, type, model, user interactivity, application, and region.
The services segment is estimated to account for the largest share of the global CDSS market, by component, in 2016. However, due to the need for periodic software upgradation, the software segment is expected to witness the highest growth during the forecast period.
Web-based CDSS segment is expected to command the largest share of the global CDSS market, by delivery mode, in 2016. However, the market for cloud-based solutions is expected to witness the highest growth rate in the forecast period.
Download PDF Brochure@
http://www.marketsandmarkets.com/pdfdownload.asp?id=18085342
Integrated CDSS segment is expected to account for the largest share of the CDSS market, by product, in 2016 and also witness the highest growth during the forecast period.
Therapeutic CDSS segment is expected to command the largest share of the global CDSS market, by type, in 2016 and is estimated to grow at the highest rate in the forecast period.
Knowledge-based CDSS segment is expected to command the largest share of the global CDSS market, by model, in 2016 and is estimated to grow at the highest rate in the forecast period.
By interactivity, active CDSS segment is expected to command the largest share of the global CDSS market in 2016, and is estimated to grow at the highest rate in the forecast period.
Get The Sample Pages Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=18085342
The conventional CDSS segment is expected to command the largest share of the global CDSS market, by application, in 2016. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence based decision making, treatment planning and protocol validation among others.
Geographically, the global CDSS market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is relatively nascent; however it is projected to be the fastest growing market in the forecast period.
Cerner Corporation (U.S.), McKesson Corporation (U.S.), Epic Systems Corporation Inc. (U.S.), Medical Information Technology, Inc. (U.S.), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (U.S.), Wolters Kluwer Health (U.S.), Zynx Health (U.S.), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (U.S.) are the key players in the global CDSS market.
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
http://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html
Early buyers will receive 10% customization on this report.
In this report, the global CDSS market is segmented on the basis of component, delivery mode, product, type, model, user interactivity, application, and region.
The services segment is estimated to account for the largest share of the global CDSS market, by component, in 2016. However, due to the need for periodic software upgradation, the software segment is expected to witness the highest growth during the forecast period.
Web-based CDSS segment is expected to command the largest share of the global CDSS market, by delivery mode, in 2016. However, the market for cloud-based solutions is expected to witness the highest growth rate in the forecast period.
Download PDF Brochure@
http://www.marketsandmarkets.com/pdfdownload.asp?id=18085342
Integrated CDSS segment is expected to account for the largest share of the CDSS market, by product, in 2016 and also witness the highest growth during the forecast period.
Therapeutic CDSS segment is expected to command the largest share of the global CDSS market, by type, in 2016 and is estimated to grow at the highest rate in the forecast period.
Knowledge-based CDSS segment is expected to command the largest share of the global CDSS market, by model, in 2016 and is estimated to grow at the highest rate in the forecast period.
By interactivity, active CDSS segment is expected to command the largest share of the global CDSS market in 2016, and is estimated to grow at the highest rate in the forecast period.
Get The Sample Pages Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=18085342
The conventional CDSS segment is expected to command the largest share of the global CDSS market, by application, in 2016. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence based decision making, treatment planning and protocol validation among others.
Geographically, the global CDSS market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is relatively nascent; however it is projected to be the fastest growing market in the forecast period.
Cerner Corporation (U.S.), McKesson Corporation (U.S.), Epic Systems Corporation Inc. (U.S.), Medical Information Technology, Inc. (U.S.), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (U.S.), Wolters Kluwer Health (U.S.), Zynx Health (U.S.), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (U.S.) are the key players in the global CDSS market.
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
Contact Information:
MarketsandMarkets™
Mr. Rohan
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketsandMarkets™
Mr. Rohan
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results